Literature DB >> 30031200

An alternative under-valve approach to ablate right-sided accessory pathways.

Jun Yang1, Gang Yang2, Hongwu Chen2, Weizhu Ju2, Bing Yang2, Fengxiang Zhang2, Yan Jin3, Jianing Cao3, Lingmei Qian4, Minglong Chen2.   

Abstract

BACKGROUND: Right-sided accessory pathway (RAP) ablation is sometimes challenging.
OBJECTIVE: Our study aimed to demonstrate an alternative ablation approach to RAPs under the tricuspid valve, especially when the conventional ablation attempts at the atrial side failed.
METHODS: Twelve patients with RAPs were enrolled, 8 of whom had previously failed ablation. With the help of a long sheath, the under-valve approach was attempted in 3 patients during tachycardia, in 2 patients during ventricular pacing, and in 7 patients during sinus rhythm. Three-dimensional electroanatomic mapping was performed in 3 patients during their repeat procedures.
RESULTS: The acute outcomes of the procedures in all patients were successful. Patients were free of tachycardia or recurrence of accessory pathway conduction during a median follow-up of 12.5 months (range 7-45 months). No complications were found during the procedure or follow-up period.
CONCLUSION: Radiofrequency ablation under the tricuspid valve to eliminate RAPs is feasible because of its stable contact and the accurate ablation of the ventricular insertion site. It provides an alternative approach to tough RAP ablation.
Copyright © 2018 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrioventricular reciprocating tachycardia; Catheter ablation; Radiofrequency; Right-sided accessory pathway; Wolff-Parkinson-White syndrome

Year:  2018        PMID: 30031200     DOI: 10.1016/j.hrthm.2018.07.022

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  1 in total

1.  A subvalvular catheter approach for radiofrequency ablation of right-sided accessory pathways.

Authors:  Marcus Wieczorek; Sharam Tajtaraghi; Reinhard Hoeltgen
Journal:  J Interv Card Electrophysiol       Date:  2019-08-05       Impact factor: 1.900

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.